Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort - Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509 IRMAIC Access content directly
Journal Articles Journal of The American Academy of Dermatology Year : 2023

Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort

Camille Leleu
  • Function : Author

Domains

Dermatology
Fichier principal
Vignette du fichier
Vanlerberghe et al. - 2022 - Effectiveness and tolerance of Janus kinase inhibi.pdf (203.5 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03903864 , version 1 (16-12-2022)

Identifiers

Cite

Julia Vanlerberghe, Frédéric Dezoteux, Claire Martin, Marie Jachiet, Angèle Soria, et al.. Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Journal of The American Academy of Dermatology, 2023, 88 (4), pp.900-904. ⟨10.1016/j.jaad.2022.10.034⟩. ⟨hal-03903864⟩
200 View
79 Download

Altmetric

Share

Gmail Facebook X LinkedIn More